Seoul Pharma Co. Ltd (018680) — Cash Flow Reinvestment Rate
Seoul Pharma Co. Ltd (018680) has a Cash Flow Reinvestment Rate of 0.52x as of June 2025, reinvesting ₩1.07 Billion (capex ₩89.75 Million plus investments ₩979.26 Million) from operating cash flow of ₩2.07 Billion. Check cash flow quality index of Seoul Pharma Co. Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Seoul Pharma Co. Ltd Cash Flow Reinvestment Rate (2009–2023)
Historical reinvestment intensity for Seoul Pharma Co. Ltd across 8 annual periods. Explore investment intensity of Seoul Pharma Co. Ltd to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Seoul Pharma Co. Ltd (2009–2023)
Year-by-year capital reinvestment analysis for Seoul Pharma Co. Ltd. For live market cap and broader valuation context, see 018680 market cap overview.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.47x | ₩7.76 Billion | ₩5.26 Billion | ₩1.89 Billion | ▲ +776.4% |
| 2020 | 0.17x | ₩964.40 Million | ₩5.74 Billion | ₩671.25 Million | ▲ +214.7% |
| 2019 | 0.05x | ₩156.43 Million | ₩2.93 Billion | ₩156.43 Million | ▼ -94.7% |
| 2015 | 1.01x | ₩1.43 Billion | ₩1.42 Billion | ₩1.40 Billion | ▼ -43.8% |
| 2014 | 1.80x | ₩2.66 Billion | ₩1.48 Billion | ₩2.62 Billion | ▼ -7.8% |
| 2012 | 1.95x | ₩17.95 Billion | ₩9.22 Billion | ₩17.95 Billion | ▲ +71.3% |
| 2011 | 1.14x | ₩5.53 Billion | ₩4.86 Billion | ₩5.43 Billion | ▼ -78.8% |
| 2009 | 5.36x | ₩6.62 Billion | ₩1.23 Billion | ₩6.11 Billion | — |